Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection.

导出 OA

翻译打印收藏纠错

作者： Haya,Ascher-Svanum ^[1] ; Diego,Novick ^[2] ; Josep Maria,Haro ^[3] ; Jordan,Bertsch ^[3] ; David,McDonnell ^[1] ; Holland,Detke ^[1]

作者单位： Eli Lilly and Company, Indianapolis, IN, USA. ^[1] Eli Lilly and Company, Windlesham, Surrey, UK ; Departament de Psiquiatria, Universitat Autonoma de Barcelona, Spain. ^[2] Parc Sanitari Sant Joan de Déu, Centro de Investigación Biomédica en Red en el Área de Salud Mental, Universitat de Barcelona, Barcelona, Spain. ^[3]

关键词 antipsychotics functioning olanzapine long-acting injection quality of life schizophrenia

DOI 10.2147/NDT.S61409

PMID 25018631

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览62

Neuropsychiatric disease and treatment

2014年10卷

1125-31页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection.

Neuropsychiatric disease and treatment

相似文献

Neuropsychiatric disease and treatment

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection.

Neuropsychiatric disease and treatment

相似文献

Neuropsychiatric disease and treatment

相关期刊

检索历史清除